Skip to main content
. Author manuscript; available in PMC: 2007 Apr 1.
Published in final edited form as: Am J Physiol Endocrinol Metab. 2006 Apr;290(4):E678–E684. doi: 10.1152/ajpendo.00383.2005

Table 3.

P values of main effects of repeated-measures ANOVAs for end points reported in Figs. 1, 3, and 4

P Values
Glucose GIR EPI NE Cort GGN Insulin
Group < 0.0001 < 0.0001 0.2656 0.3721 0.7270 0.2161 0.3902
Day < 0.0001 < 0.0001 0.0783 0.8777 0.1823 0.1828 0.8401
Group × day < 0.0001 < 0.0001 0.0427 0.3355 0.0290 0.0166 0.7957
Time < 0.0001 < 0.0001 0.0015 0.8083 < 0.0001 0.0005 < 0.0001
Group × time < 0.0001 0.1997 0.877 0.2522 0.0994 0.5500 0.9381
Day × time < 0.0001 0.7175 0.0927 0.6793 0.0029 0.4272 0.9446
Group × day × time <0.0001 < 0.0001 0.0151 0.7859 0.0019 0.0491 0.6948

EPI, epinephrine; NE, norepinephrine; Cort, corticosterone; GGN, glucagon. Group refers to whether mice were hypoglycemic or euglycemic on day 1. Day indicates day 1 vs. day 2 hyperinsulinemic glucose clamps. Time refers to time during a given glucose clamp. Significant values (P < 0.05) are highlighted in bold.